FIRAPY Showcased at OSNT Conference 2024 in Salalah, Oman

ch.chou . • October 10, 2024

FIRAPY Showcased at OSNT Conference 2024 in Salalah, Oman

We are thrilled to share our successful participation in the Second OSNT International Conference held from September 5–7, 2024, in Salalah, Oman. The conference brought together nephrology experts, dialysis clinicians, and healthcare innovators from across the globe to explore cutting-edge solutions in nephrology care.

FIRAPY's journey to Oman is a story of global collaboration. It was first discovered by Mr. Hamed, an OSNT member, during his advanced studies in the United Kingdom. Recognizing its innovative potential, he made it his mission to introduce FIRAPY to Oman, where it is now gaining attention for its ability to improve dialysis fistula function, enhance microcirculation, and address ischemia-related complications.

At our booth, FIRAPY garnered significant interest from attendees eager to learn more about its non-invasive and evidence-based approach to vascular health management. Interactive presentations and in-depth discussions highlighted FIRAPY's inclusion in clinical guidelines and its proven effectiveness in improving outcomes for dialysis patients.

The event also provided us with a unique platform to connect with key opinion leaders and potential distributors, particularly in the MENA region. We extend our gratitude to the OSNT organizing committee, especially Mr. Hamed, for his support and hospitality, as well as to the numerous healthcare professionals who visited our booth.

As FIRAPY continues to make a global impact, we invite healthcare providers and distributors worldwide to join us in transforming vascular therapy. Stay tuned for more updates on upcoming events and innovations!

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
FIRAPY collaborates with Taipei Veterans General Hospital in research on non-invasive therapies for

FIRAPY Supports Clinical Research Advancing Non-Invasive Therapies for Peritoneal Dialysis

July 2, 2025
FIRAPY and Taipei Veterans General Hospital co-published a study in JFMA showing improved cardiovascular and infection outcomes in peritoneal dialysis patients using far-infrared therapy.
FIR improves cardiovascular and infectious outcomes inPD patients

Far-infrared therapy improves cardiovascular and infectious outcomes in peritoneal dialysis patients

July 2, 2025
Abstract

FIRAPY to Exhibit at 70th JSDT Annual Meeting in Yokohama

June 17, 2025
We are pleased to announce that FIRAPY will be exhibiting at the 70th Annual Meeting of the Japanese Society for Dialysis Therapy (JSDT) , to be held in OSAKA , Japan , from June 27-29, 2025 . 📍 Booth No.: ⑩-96 📅 June 27–29, 2025 📌 Osaka International Convention Center 🔗 Event Website (Japanese) FIRAPY is now adopted by over 200 dialysis facilities across Japan , where it has been used in daily clinical practice to support fistula function maintenance and foot care . With this extensive local experience, FIRAPY has become an important part of non-invasive treatment for Japanese HD patients. We look forward to sharing our latest clinical insights and field experiences at JSDT 2025. If you are attending, we warmly welcome you to stop by Booth ⑩-96 and learn more about how FIRAPY is making a difference in dialysis care. See you in Osaka!
More Posts